We are live on ! Find out more
VNDA icon

Vanda Pharmaceuticals
VNDA

188 hedge funds and large institutions have $371M invested in Vanda Pharmaceuticals in 2023 Q2 according to their latest regulatory filings, with 22 funds opening new positions, 76 increasing their positions, 61 reducing their positions, and 11 closing their positions.

New
Increased
Maintained
Reduced
Closed

2,027% more call options, than puts

Call options by funds: $638K | Put options by funds: $30K

100% more first-time investments, than exits

New positions opened: 22 | Existing positions closed: 11

25% more repeat investments, than reductions

Existing positions increased: 76 | Existing positions reduced: 61

6% more funds holding

Funds holding: 177 → 188 (+11)

4.62% less ownership

Funds ownership: 102.55% → 97.93% (-4.6%)

6% less capital invested

Capital invested by funds: $396M → $371M (-$25M)

Holders
188
Holders Change
+11
Holders Change %
+6.21%
% of All Funds
2.95%
Holding in Top 10
1
Holding in Top 10 Change
+1
Holding in Top 10 Change %
% of All Funds
0.02%
New
22
Increased
76
Reduced
61
Closed
11
Calls
$638K
Puts
$30K
Net Calls
+$608K
Net Calls Change
+$624K

Top Buyers

Rank Fund Capital Flow
1
BlackRock
BlackRock
New York
+$4.56M
2
Goldman Sachs
Goldman Sachs
New York
+$2.9M
3
PAMS
Pictet Asset Management (Switzerland)
Switzerland
+$2.23M
4
Bank of Montreal
Bank of Montreal
Ontario, Canada
+$1.84M
5
Man Group
Man Group
United Kingdom
+$1.75M

Top Sellers

Rank Fund Capital Flow
1
Bank of America
Bank of America
North Carolina
-$8.28M
2
Millennium Management
Millennium Management
New York
-$7.58M
3
Dimensional Fund Advisors
Dimensional Fund Advisors
Texas
-$5.35M
4
EIP
Epoch Investment Partners
New York
-$4.8M
5
Allspring Global Investments
Allspring Global Investments
North Carolina
-$3.83M
Name Holding Trade Value Shares
Change 		Change in
Stake
BNP Paribas Financial Markets
76
BNP Paribas Financial Markets
France
$514K -$539K -84,080 -52%
Royal Bank of Canada
77
Royal Bank of Canada
Ontario, Canada
$498K +$43.3K +6,761 +10%
AllianceBernstein
78
AllianceBernstein
Tennessee
$497K +$75.3K +11,740 +18%
Ensign Peak Advisors
79
Ensign Peak Advisors
Utah
$493K – – –
ECM
80
ExodusPoint Capital Management
New York
$486K +$473K +73,822 New
CS
81
Credit Suisse
Switzerland
$466K +$137K +21,355 +43%
California State Teachers Retirement System (CalSTRS)
82
California State Teachers Retirement System (CalSTRS)
California
$453K -$10.3K -1,611 -2%
CAM
83
ClariVest Asset Management
California
$442K +$157K +24,481 +58%
MAM
84
Martingale Asset Management
Massachusetts
$441K +$117K +18,303 +38%
Ohio Public Employees Retirement System (OPERS)
85
Ohio Public Employees Retirement System (OPERS)
Ohio
$439K – – –
Squarepoint
86
Squarepoint
New York
$432K +$420K +65,537 New
COPPSERS
87
Commonwealth of Pennsylvania Public School Employees Retirement System
Pennsylvania
$428K +$30.8K +4,808 +8%
Wells Fargo
88
Wells Fargo
California
$410K +$67.1K +10,463 +20%
NYLIM
89
New York Life Investment Management
New York
$400K -$51.1K -7,968 -12%
SO
90
STRS Ohio
Ohio
$382K +$28.8K +4,500 +8%
PAM
91
Panagora Asset Management
Massachusetts
$376K -$814K -127,044 -69%
VEA
92
Virtus ETF Advisers
New York
$361K +$78.6K +12,265 +29%
VRS
93
Virginia Retirement Systems
Virginia
$345K +$12.2K +1,900 +4%
SIM
94
SummerHaven Investment Management
Connecticut
$344K -$123K -19,191 -27%
AIMCA
95
Alberta Investment Management Corp (AIMCo)
Alberta, Canada
$335K – – –
TPSF
96
Texas Permanent School Fund
Texas
$328K -$2.36K -368 -0.7%
Robeco Institutional Asset Management
97
Robeco Institutional Asset Management
Netherlands
$327K – – –
DT
98
Diversified Trust
Tennessee
$309K +$171K +26,605 +131%
CCIA
99
Campbell & Co Investment Adviser
Maryland
$297K +$289K +45,011 New
Jane Street
100
Jane Street
New York
$282K +$274K +42,793 New
2 3
4
5 6

VNDA Hedge Fund Activity: Q2 2023 in Review

188 of the 6,369 institutional investors tracked by Wall St. Rank reported a position in Vanda Pharmaceuticals (VNDA) for Q2 2023, worth a combined $371M — down 6.3% from $396M a quarter earlier.

Buyers outnumbered sellers: 22 funds opened new VNDA positions and 11 closed out — a net gain of 11 holders — while 76 added to existing stakes and 61 trimmed.

The largest buyer was BlackRock, adding an estimated $4.56M. The largest seller was Bank of America, cutting an estimated $8.28M.

  • 188 institutional investors held Vanda Pharmaceuticals (VNDA) as of Q2 2023, up from 177 in Q1 2023.
  • Funds reported $371M of Vanda Pharmaceuticals stock for Q2 2023, down 6.3% quarter-over-quarter.
  • 22 funds opened new Vanda Pharmaceuticals positions in Q2 2023 and 11 closed out, a net change of +11 holders.
  • The largest Vanda Pharmaceuticals buyer in Q2 2023 was BlackRock, an estimated $4.56M added.
  • The largest Vanda Pharmaceuticals seller in Q2 2023 was Bank of America, an estimated $8.28M sold.

Based on aggregated 13F filings for Q2 2023.